Back to search
Thyroid Papillary Carcinoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Thyroid Papillary Carcinoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Thyroid Papillary Carcinoma trials you may qualify forParticipants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to furthe…
To develop and validate a structured scoring tool (robotic thyroidectomy assessment score, RTAS) for assessing and quantifying surgical performance in robotic t…
This study is to evaluate the effectiveness of nsPFA in treating papillary thyroid microcarcinoma. T
1. To evaluate the clinical outcomes of ultrasound-guided thermal ablation and thyroid surgery for the treatment of papillary thyroid carcinoma; 2. To develop a…
To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who ha…
This study is a phase III, randomized controlled, open label non inferiority study. Patients who meet the inclusion criteria are randomly assigned 1:1 to either…
IoN is a phase II/III trial that will look to ascertain whether or not radio-iodine ablation is necessary for low risk differentiated thyroid cancer patients.
Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy and is frequently associated with microscopic central neck lymph node metastases, even…